Peptide for use in chronic complications of diabetes

Developed by: Instituto de Investigación Sanitaria Fundación Jiménez Díaz

Description

Description

SOCS1-derived peptide for prevention and treatment of chronic complications of diabetes, especially complications affecting the kidneys, nervous and vascular systems.

Applications

Diabetic nephropathy, age-related macular degeneration, glaucoma and pigmentary retinitis, diabetic nephropathy,

diabetic angiopathy, diabetic microangiopathy, diabetic macroangiopathy, diabetic atherosclerosis, diabetic foot, and peripheral arterial disease.

Protection status

Co-ownership of the invention.

Request for national patent submitted to the Spanish Patent and Trademark Office.

International application requested via co-ownership of the patent.

Cooperation requested

Search for licensees for the patent

Search for partners to undertake joint development of the technology

Therapy area

Ophthalmology

Nephrology

Cardiology

Status:
N/A
Health technology:
N/A